Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Boehringer Ingelheim discovers TRPA1 antagonists

May 6, 2021

SAN-903 reduces lung inflammation and fibrosis in mouse model of IPF

May 4, 2021

Mesoblast reports 60-day results on remestemcel-L in COVID-19 related ARDS

April 30, 2021

New IRAK-4 inhibitors identified at Bayer

April 28, 2021

CL-2020 studied for ARDS related to COVID-19 in Japan

April 21, 2021

Phase II study application for FB-704A in severe asthma receives approval in Taiwan

April 21, 2021

Krystal Biotech provides development updates for KB-407 and KB-408

April 21, 2021

Nanjing TransThera Biosciences patents PADI4 inhibitors

April 19, 2021

scRNA-seq and gene expression analysis of lung immune cells in a model of RA-associated lung disease

April 13, 2021

EpiEndo begins first-in-human trial of EP-395 for chronic airway diseases

April 13, 2021

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...